Related Experiment Videos
[Clinical experience with sultamicillin fine granules in pediatric field]
T Haruta1, S Kuroki, H Yamamoto
1Department of Pediatrics, Kobe Central Municipal Hospital.
The Japanese Journal of Antibiotics
|December 1, 1988
Summary
Sultamicillin fine granules demonstrated high clinical efficacy (94.4%) in pediatric infections, with good tolerability and palatability. Bacteriological eradication rates reached 70.6%, even against some beta-lactamase-producing strains.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacology
- Antimicrobial Therapy
Context:
- Pediatric infections require effective and well-tolerated antibiotic treatments.
- Sultamicillin is a prodrug of ampicillin and sulbactam, offering broad-spectrum activity.
- Evaluating new formulations like fine granules is crucial for improving pediatric compliance.
Purpose:
- To assess the clinical and bacteriological efficacy of sultamicillin fine granules in pediatric patients.
- To evaluate the safety and tolerability profile of oral sultamicillin in children.
- To determine the drug's acceptance by pediatric patients based on taste and smell.
Summary:
- Oral sultamicillin fine granules were administered to 18 pediatric patients with various infections.
- High clinical efficacy (94.4%) was observed, particularly in tonsillitis (81.3% excellent, 12.5% good).
- Bacteriological efficacy was 70.6% for targeted strains, including some beta-lactamase producers. Side effects were mild, with diarrhea noted in two cases. The formulation was well-accepted by children.
Impact:
- Sultamicillin fine granules present a viable and effective treatment option for common pediatric infections.
- The palatable formulation may improve adherence and therapeutic outcomes in pediatric populations.
- This study supports the use of sultamicillin in pediatric practice, highlighting its favorable safety and efficacy profile.